Clinical Focus

  • Internal Medicine
  • Women's Health
  • Behavioral Medicine

Academic Appointments

Administrative Appointments

  • Site Director, Internal Medicine Residency Program (2016 - Present)

Professional Education

  • Board Certification: American Board of Internal Medicine, Internal Medicine (2005)
  • Residency: UCSF-Graduate Medical Education (2001) CA
  • Medical Education: Univ of California San Francisco (1997) CA
  • M.D., U.C. San Francisco, Medicine (1997)
  • Ph.D., U.C. San Francisco, Psychology (1991)
  • B.A, San Jose State University, Psychology Neuroscience (1985)

2021-22 Courses

All Publications

  • Completion Rate and Side-Effect Profile of Three-Month Isoniazid and Rifapentine Treatment for Latent Tuberculosis Infection in an Urban County Jail. Open forum infectious diseases Juarez-Reyes, M., Gallivan, M., Chyorny, A., O'Keeffe, L., Shah, N. S. 2016; 3 (1): ofv220-?


    In an urban jail population, 3 months of isoniazid and rifapentine (3HP) was associated with an 85% latent tuberculosis infection treatment completion rate compared with 18% in a standard 9-month isoniazid treatment group. Among the 91 patients who started 3HP therapy, there were 2 treatment discontinuations from adverse drug reactions.

    View details for DOI 10.1093/ofid/ofv220

    View details for PubMedID 26885547

    View details for PubMedCentralID PMC4753347